News Focus
News Focus
Post# of 257262
Next 10
Followers 1
Posts 202
Boards Moderated 0
Alias Born 01/23/2008

Re: DewDiligence post# 58322

Tuesday, 01/29/2008 9:01:57 PM

Tuesday, January 29, 2008 9:01:57 PM

Post# of 257262
What do you guys think about THeratechnologies sale process? do you think their drug will get approved. i highly doubt they will get approval due to FDA scrutiny on safety. potential elevation of glucose levels. similar drug by genzyme got rejected last year.

also, new anti-retrovirals - lipodystrophy not seen as much.
company probably tried to shop themselves below the radar starting 2H07, but no partners, no buyers.

i think high risk, drug likely not approved.


UPDATE 1-Theratechnologies mulls options, could sell, merge
Tue Jan 29, 2008 8:45am ESTPost Your Comments | All Comments


TORONTO, Jan 29 (Reuters) - Theratechnologies Inc (TH.TO: Quote, Profile, Research) said on Tuesday it is considering strategic options, including a sale or merger of the company, as well as the licensing of its lead compound tesamorelin.

As part of the review of its options, the company has filed for a preliminary base shelf prospectus that would allow it to issue up to C$35 million of common shares.

The Montreal-based firm said a committee of independent directors would oversee the review, and that it has hired Lazard and BMO Capital Markets as advisors.

It said the strategy to develop and commercialize tesamorelin -- which treats HIV-associated lipodystrophy, a disease that increases central fat accumulation in the bodies of HIV-infected patients -- was on schedule.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today